Journal of International Reproductive Health/Family Planning ›› 2024, Vol. 43 ›› Issue (6): 524-528.doi: 10.12280/gjszjk.20240343
• Review • Previous Articles
YANG Qin, WANG Han-ting, CAO Yuan-yuan, ZHOU Jun, WANG Gui-ling()
Received:
2024-07-18
Published:
2024-11-15
Online:
2024-11-12
Contact:
WANG Gui-ling, E-mail: wangguiling666@sina.com
YANG Qin, WANG Han-ting, CAO Yuan-yuan, ZHOU Jun, WANG Gui-ling. Effect of Resveratrol on the Function of Ovarian Granulose Cells[J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 524-528.
Add to citation manager EndNote|Ris|BibTeX
[1] | Gou M, Li J, Yi L, et al. Reprogramming of ovarian aging epigenome by resveratrol[J]. PNAS Nexus, 2023, 2(2):pgac310. doi: 10.1093/pnasnexus/pgac310. |
[2] | Wang D, Geng M, Gan D, et al. Effect of resveratrol on mouse ovarian vitrification and transplantation[J]. Reprod Biol Endocrinol, 2021, 19(1):54. doi: 10.1186/s12958-021-00735-y. |
[3] | 宋亭嶙, 方兰兰. 白藜芦醇调控卵巢功能作用的研究进展[J]. 生殖医学杂志, 2023, 32(7):1127-1131. doi: 10.3969/j.issn.1004-3845.2023.07.025. |
[4] |
Tiwari M, Tripathi A, Chaube SK. Presence of encircling granulosa cells protects against oxidative stress-induced apoptosis in rat eggs cultured in vitro[J]. Apoptosis, 2017, 22(1):98-107. doi: 10.1007/s10495-016-1324-4.
pmid: 27817140 |
[5] | Jiang X, Ma Y, Gong S, et al. Resveratrol Promotes Proliferation, Antioxidant Properties, and Progesterone Production in Yak (Bos grunniens) Granulosa Cells[J]. Animals(Basel), 2024, 14(2):240. doi: 10.3390/ani14020240. |
[6] | Morita Y, Wada-Hiraike O, Yano T, et al. Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary[J]. Reprod Biol Endocrinol, 2012,10:14. doi: 10.1186/1477-7827-10-14. |
[7] |
Song T, Chen J, Yang S, et al. Resveratrol stimulates StAR expression and progesterone production by GPER-mediated downregulation of Snail expression in human granulosa cells[J]. J Food Drug Anal, 2023, 31(2):315-325. doi: 10.38212/2224-6614.3460.
pmid: 37335164 |
[8] |
Grive KJ, Sauerbrun-Cutler MT. Resveratrol improves granulosa cell activity through mitochondrial biogenesis[J]. Fertil Steril, 2021, 115(4):909-910. doi: 10.1016/j.fertnstert.2021.02.011.
pmid: 33832750 |
[9] |
Ragonese F, Monarca L, De Luca A, et al. Resveratrol depolarizes the membrane potential in human granulosa cells and promotes mitochondrial biogenesis[J]. Fertil Steril, 2021, 115(4):1063-1073. doi: 10.1016/j.fertnstert.2020.08.016.
pmid: 33487442 |
[10] | 平大冰, 齐婧姝, 孙鑫, 等. 全反式维甲酸对肝纤维化氧化应激损伤自然杀伤细胞的保护作用[J]. 中国免疫学杂志, 2024, 40(7):1359-1363. doi: 10.3969/j.issn.1000-484X.2024.07.003. |
[11] | 邓煜, 马智, 胡俊, 等. 白藜芦醇调节SIRT1/AMPK通路抑制大鼠多囊卵巢综合征颗粒细胞内自噬的机制研究[J]. 重庆医科大学学报, 2022, 47(6):700-704. doi: 10.13406/j.cnki.cyxb.003042. |
[12] | 吴海峰, 贾建雷, 李倩, 等. 白藜芦醇通过调节SIRT1改善环磷酰胺诱导的人颗粒细胞氧化应激损伤[J]. 河北医科大学学报, 2022, 43(7):832-838. doi: 10.3969/j.issn.1007-3205.2022.07.018. |
[13] | Nie Z, Hua R, Zhang Y, et al. Resveratrol protects human luteinised granulosa cells against hydrogen peroxide-induced oxidative injury through the Sirt1[J]. Reprod Fertil Dev, 2021, 33(16):831-840. doi: 10.1071/RD21069. |
[14] |
Nishigaki A, Kido T, Kida N, et al. Resveratrol protects mitochondrial quantity by activating SIRT1/PGC-1α expression during ovarian hypoxia[J]. Reprod Med Biol, 2020, 19(2):189-197. doi: 10.1002/rmb2.12323.
pmid: 32273826 |
[15] | Cai M, Wang J, Sun H, et al. Resveratrol Attenuates Hydrogen Peroxide-induced Injury of Rat Ovarian Granulosa-lutein Cells by Resisting Oxidative Stress via the SIRT1/Nrf2/ARE Signaling Pathway[J]. Curr Pharm Des, 2023, 29(12):947-956. doi: 10.2174/1381612829666230403133322. |
[16] | Li N, Liu L. Mechanism of resveratrol in improving ovarian function in a rat model of premature ovarian insufficiency[J]. J Obstet Gynaecol Res, 2018, 44(8):1431-1438. doi: 10.1111/jog.13680. |
[17] |
Chen M, He C, Zhu K, et al. Resveratrol ameliorates polycystic ovary syndrome via transzonal projections within oocyte-granulosa cell communication[J]. Theranostics, 2022, 12(2):782-795. doi: 10.7150/thno.67167.
pmid: 34976213 |
[18] |
Schube U, Nowicki M, Jogschies P, et al. Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration[J]. J Clin Endocrinol Metab, 2014, 99(1):229-239. doi: 10.1210/jc.2013-2692.
pmid: 24170104 |
[19] | Cai M, Sun H, Huang Y, et al. Resveratrol Protects Rat Ovarian Luteinized Granulosa Cells from H2O2-Induced Dysfunction by Activating Autophagy[J]. Int J Mol Sci, 2023, 24(13):10914. doi: 10.3390/ijms241310914. |
[20] | Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome[J]. Nat Rev Dis Primers, 2016,2:16057. doi: 10.1038/nrdp.2016.57. |
[21] | Bahramrezaie M, Amidi F, Aleyasin A, et al. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial[J]. J Assist Reprod Genet, 2019, 36(8):1701-1712. doi: 10.1007/s10815-019-01461-6. |
[22] | Liang A, Zhang W, Wang Q, et al. Resveratrol regulates insulin resistance to improve the glycolytic pathway by activating SIRT2 in PCOS granulosa cells[J]. Front Nutr, 2022,9:1019562. doi: 10.3389/fnut.2022.1019562. |
[23] | Huo P, Li M, Le J, et al. Resveratrol improves follicular development of PCOS rats via regulating glycolysis pathway and targeting SIRT1[J]. Syst Biol Reprod Med, 2023, 69(2):153-165. doi: 10.1080/19396368.2022.2125855. |
[24] | Fang L, Yu Y, Li Y, et al. Upregulation of AREG, EGFR, and HER2 contributes to increased VEGF expression in granulosa cells of patients with OHSS?[J]. Biol Reprod, 2019, 101(2):426-432. doi: 10.1093/biolre/ioz091. |
[25] | 谭慧芳, 祁秀娟, 丁钰, 等. 卵巢过度刺激综合征与卵泡液血管内皮生长因子和色素上皮衍生因子水平的关系[J]. 生殖医学杂志, 2013, 22(3):171-176. doi: 10.3969/j.issn.1004-3845.2013.03.006. |
[26] |
Ozgur S, Oktem M, Altinkaya SO, et al. The effects of resveratrol on ovarian hyperstimulation syndrome in a rat model[J]. Taiwan J Obstet Gynecol, 2018, 57(3):383-388. doi: 10.1016/j.tjog.2018.04.010.
pmid: 29880170 |
[27] | Tal R, Seifer DB. Ovarian reserve testing: a user′s guide[J]. Am J Obstet Gynecol, 2017, 217(2):129-140. doi: 10.1016/j.ajog.2017.02.027. |
[28] | 郭路, 刘晓程, 马淼, 等. 早发性卵巢功能不全患者中SIRT1与氧化应激的相关性研究[J]. 老年医学与保健, 2020, 26(6):908-913. doi: 10.3969/j.issn.1008-8296.2020.06.005. |
[29] | 郭路, 刘晓程, 顾超, 等. SIRT1-cAMP在白藜芦醇改善小鼠卵巢储备中的作用[J]. 复旦学报(医学版), 2022, 49(4):529-536. doi: 10.3969/j.issn.1672-8467.2022.04.008. |
[30] |
Zhang T, Du X, Zhao L, et al. SIRT1 facilitates primordial follicle recruitment independent of deacetylase activity through directly modulating Akt1 and mTOR transcription[J]. FASEB J, 2019, 33(12):14703-14716. doi: 10.1096/fj.201900782R.
pmid: 31693862 |
[31] | Moreira-Pinto B, Costa L, Felgueira E, et al. Low Doses of Resveratrol Protect Human Granulosa Cells from Induced-Oxidative Stress[J]. Antioxidants(Basel), 2021, 10(4):561. doi: 10.3390/antiox10040561. |
[32] | Yan S, Gao Z, Ding J, et al. Nanocomposites based on nanoceria regulate the immune microenvironment for the treatment of polycystic ovary syndrome[J]. J Nanobiotechnology, 2023, 21(1):412. doi: 10.1186/s12951-023-02182-w. |
[33] |
Hu B, Zheng X, Zhang W. Resveratrol-βcd inhibited premature ovarian insufficiency progression by regulating granulosa cell autophagy[J]. J Ovarian Res, 2024, 17(1):18. doi: 10.1186/s13048-024-01344-0.
pmid: 38221630 |
[34] | 杨洋. 白藜芦醇对人IVF阻滞胚胎发育和高龄卵巢颗粒细胞氧化损伤的作用机制研究[D]. 上海: 上海中医药大学, 2021. |
[35] | Gorshinova VK, Tsvirkun DV, Sukhanova IA, et al. Cumulus cell mitochondrial activity in relation to body mass index in women undergoing assisted reproductive therapy[J]. BBA Clin, 2017, 7:141-146. doi: 10.1016/j.bbacli.2017.03.005. |
[1] | BAI Ruo-yan, WANG Yan-qiang, CHEN Jing-xia. A Case of Brain Abscess Secondary to Intrauterine Device-Related Ovarian Abscess in A Postmenopausal Woman [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 485-489. |
[2] | LI An-qi, ZHU Meng-yi, WANG Yu, GAO Jing-shu, WU Xiao-ke. Potential Application of Tanshinone in the Treatment of Polycystic Ovary Syndrome and Mechanism [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 494-500. |
[3] | LEI Rui-xiang, WAN Yi, LI Yu-zi, GUAN De-feng, ZHANG Xue-hong. Association of Circadian Rhythm Disorders with Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 501-505. |
[4] | QIAO Xin-yue, TAO Ai-lin, FENG Xiao-ling, CHEN Lu. Research on the Correlation between Polycystic Ovary Syndrome and Anxiety and Depression Disorders [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 506-511. |
[5] | TIAN Dejier, FENG Xiao-ling. Possible Application of Myo-Inositol and D-Chiro-Inositol in Treatment of Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 512-517. |
[6] | GAO Zheng, LI Meng-yuan, LI Bo, LIANG Jing-qiao, ZHANG Ya-dong, XU Xin. Efficacy of Chinese Medicine Compound on Abnormal Glucose and Lipid Metabolism in Patients with Obese Polycystic Ovary Syndrome: A Meta Analysis [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 368-377. |
[7] | ZHU Hai-ying, QI Dan-dan, SUN Ping-ping, SUN Na, LUAN Su-xian. A Case Report of Ovarian Hyperstimulation Syndrome Combined with Ovarian Torsion after Assisted Reproductive Technology Assisted Pregnancy [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 401-405. |
[8] | JIANG Nan, ZHAO Xiao-li, LUAN Zu-qian, HUANG Zhi-yun, XIA Tian. Research Progress on the Correlation between Oxidative Stress and Aneuploidy in Oocytes of Aging Women [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 415-419. |
[9] | LI Xuan-ang, WANG Ting-ting, XIANG Shan, ZHAO Shuai, LIAN Fang. Research Progress of Ferroptosis in Pathogenesis of Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 425-429. |
[10] | LI Jia-li, TU Xu-xu, WANG Shi-meng, NIU Ding-ren, FENG Xiao-ling. Recurrent Spontaneous Abortion Related to Oxidative Stress at Maternal-Fetal Interface [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 435-440. |
[11] | LI Dan-ping, LIAN Fang, XIANG Shan. New Progress in the Mechanism of Metformin Therapy for Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(4): 343-347. |
[12] | SHI Bai-chao, CHANG Hui, WANG Yu, LU Feng-juan, WANG Kai-yue, GUAN Mu-xin, MA Liang, WU Xiao-ke. The Role of Gut Microbiota in Patients with Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(3): 238-242. |
[13] | GAO Zhao-yang, ZHANG Ning-qing, CHEN Qiong-hua, WU Rong-feng. The Role of CircRNAs in Follicular Granulosa Cells of Patients with Endometriosis Infertility [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(3): 243-248. |
[14] | YE Lin, HOU Zhi-jin, MENG Yu-shi. Research Progress of Sirolimus in the Field of Reproduction [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(2): 132-137. |
[15] | DAI He-qi, MAO Fei, FENG Rui-zhi, QIAN Yun. The Role of LncRNA as CeRNA in Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(2): 144-149. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||